Title : Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma.

Pub. Date : 2021 Aug

PMID : 34210658






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma. lorlatinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
2 We describe a case of a patient with relapsed, refractory, metastatic ALK F1174L-mutated neuroblastoma who showed no response to the first generation ALK inhibitor crizotinib but had a subsequent complete response to the ALK/ROS1 inhibitor lorlatinib. lorlatinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens